Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05318183 · ClinicalTrials.gov registry record · NA

Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components

A NA study of Inflammation and PreDiabetes, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
65
Enrollment target
1
Study location

NCT05318183 is a NA study of Inflammation and PreDiabetes that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 65 participants, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05318183, a NA study of Inflammation and PreDiabetes, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
65 participants
Enrollment target
1
Study location

Study Summary

This study will investigate the gut microbiota-mediated effects of whole wheat consumption on human health in adults with pre-diabetes. Participants will complete two phases of intervention in random order in which they will consume either whole wheat bread (4 servings) or white bread a day for two weeks prior to collecting specimens (stool, urine, and plasma/serum).

Interventions

  • OTHER Whole Wheat Bread
  • OTHER White Bread (control)

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 65 participants
Start Date 2022-01-27
Est. Completion 2026-05-30
Phase NA

Sponsor

Ohio State University

552 total trials

What the Registry Record Tells You About NCT05318183

The ClinicalTrials.gov registry entry for NCT05318183 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 288-participant average among 132 other Inflammation trials with a reported enrollment target (77% lower). The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Inflammation appearing as the primary indexed condition, and to 2 interventions - of which Whole Wheat Bread is the first listed.

NCT05318183 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT05318183 about?

NCT05318183 is a clinical study titled "Assessing Gut Microbiota Mediated Health Outcomes of Whole Wheat and Its Major Bioactive Components". This study will investigate the gut microbiota-mediated effects of whole wheat consumption on human health in adults with pre-diabetes. Participants will complete two phases of intervention in random order in which they will consume either whole wheat bread (4 servings) or white bread a day for two ...

What is the current status of trial NCT05318183?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 65 participants. The study started on 2022-01-27. Estimated completion is 2026-05-30.

What conditions does trial NCT05318183 study?

This clinical trial studies the following conditions: Inflammation, PreDiabetes, Dysbiosis, Endotoxemia.

What interventions are being tested in trial NCT05318183?

The interventions under investigation include: Whole Wheat Bread (OTHER), White Bread (control) (OTHER).

Who is sponsoring clinical trial NCT05318183?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05318183 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Inflammation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.